科伦药业：公司在四川联盟和广东联盟的省区已完成报量并进入报价阶段

Group 1 - The company expects that over 70% of the national market will complete the volume-based procurement for infusion by the end of this year, which will help stabilize its core market [1] - The company has completed the reporting phase in the Sichuan and Guangdong alliances and has entered the pricing stage, anticipating positive outcomes [1]